30.12.2012 Views

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

Pharmaceutical Manufacturing Handbook: Production and

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

PACKAGING MATERIALS 163<br />

3.2.2.2 Glass as Packaging Material<br />

A packaging system found acceptable for one drug product may not be appropriate<br />

for another. Each application should contain enough information to show that each<br />

proposed container closure system <strong>and</strong> its components are suitable for the intended<br />

use.<br />

Nonsterile Products<br />

Solids Some topical drug products such as powders may be considered for marketing<br />

in glass bottles with appropriate dispenser. These topical drug products may be<br />

sterile <strong>and</strong> could be subject to microbial limits.<br />

The most common glass - packed solid oral dosage forms are oral powders <strong>and</strong><br />

granules for reconstitution. A typical solid oral dosage form container closure system<br />

is a glass bottle (although plastic bottles are also used) with a screw - on or snap - off<br />

closure. A typical closure consists of a metal cap, often with a liner <strong>and</strong> frequently<br />

with an inner seal.<br />

The dry powders that are reconstituted in their marketed container need not be<br />

sterile; however, the possibility of an interaction between the packaging components<br />

<strong>and</strong> the reconstituting fl uid can’t be discarded. Although the contact time will be<br />

relatively short when compared to the component/dosage form contact time for<br />

liquid - based oral dosage forms, it should still be taken into consideration when the<br />

compatibility <strong>and</strong> safety of the container closure system are being evaluated.<br />

Powders for oral administration that are reconstituted in their market container,<br />

however, have an additional possibility of interaction between the packaging components<br />

<strong>and</strong> the reconstituting fl uid. Although the contact time will be relatively<br />

short when compared to the component/dosage form contact time for liquid - based<br />

oral dosage forms, it should still be taken into consideration when the compatibility<br />

<strong>and</strong> safety of the container closure system are being evaluated.<br />

Nonsolids For nonsterile products the preservative provides some protection, but<br />

continual microbial challenge will diminish the effi cacy of the preservative, <strong>and</strong><br />

spoilage or disease transmission may occur [8] .<br />

Antimicrobial preservatives such as phenylmercuric acetate are known to partition<br />

into rubbers during storage, thus reducing the formulation concentration below<br />

effective antimicrobial levels [9] . A complication of modern packaging is the need<br />

for the application of security seals to protect against deliberate adulteration <strong>and</strong><br />

maintain consumer confi dence.<br />

Sterile Products The sterile dosage forms share the common attributes that they<br />

are generally solutions, emulsions, or suspensions <strong>and</strong> are all required to be sterile.<br />

Injectable dosage forms represent one of the highest risk drug products (Table 1 ).<br />

Any contaminants present (as a result of contact with a packaging component or<br />

due to the packaging system ’ s failure to provide adequate protection) can be rapidly<br />

<strong>and</strong> completely introduced into the patient ’ s general circulation. Injectable drug<br />

products may be liquids in the form of solutions, emulsions, or suspensions or dry<br />

solids that are to be combined with an appropriate vehicle to yield a solution or<br />

suspension.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!